If you would like to learn more about the studies listed here, please contact us at 215-349-8446.

Enrolling Studies: Atrial Fibrillation


Apixaban For The Reduction Of Thromboembolism In Patients With Device-Detected Sub-Clinical Atrial Fibrillation

In patients with evidence of device-detected subj-clinical atrial fibrillation (SCAF) and additional risk factors for stroke, treatment with apixaban compared with aspirin will reduce the risk of the composite of stroke and systemic embolism.


Catheter Ablation vs. Medical Therapy in Congested Hearts with AF

To determine if catheter based atrial fibrillation ablation is superior to medical treatment in patients with impaired LV function that have been diagnosed with symptomatic AF within the past 6 months


Efficacy of DE-MRI-Guided Ablation vs. Conventional Catheter Ablation of Atrial Fibrillation

To examine the efficacy of targeting atrial fibrosis tissue during an ablation procedure in treating persistent AF.


Safety of Oral Anticoagulation Therapy Withdrawal after Successful PVI

Multi-center randomized study to determine safety of withdrawing oral anticoagulation therapy (OAT) for patients who have had successful PVI as defined by no episodes of AF following procedure. Patients to be enrolled at 3-21 months post procedure. Only 12 months follow up.


Prospective Review of the Safety and Effectiveness of the SMARTTOUCH SF Catheter Evaluated for Treating Symptomatic Persistent AF

Prospective multi-center non-randomized clinical evaluation utilizing the THERMOCOOL SMARTTOUCH SF catheter compared to a predetermined performance goal.

Re-do Firm

Randomized Evaluation of Redo Ablation Procedures of Atrial Fibrillation with Focal Impulse and Rotor Modulation Guided Procedures

Evaluate the safety and effectiveness of FIRM-guided procedures in conventional repeat (“redo”) RF ablation for the treatment of paroxysmal and persistent atrial fibrillation. This is a prospective, multicenter, randomized study to assess the safety and effectiveness of FIRM-guided procedures in conventional “redo” RF ablation procedures for the treatment of persistent and paroxysmal atrial fibrillation.

Enrolling Studies: Ventricular Tachycardia


Location of Ablation to Stop VT

To determine whether the lesion sites predicted by CardioSolv’s simulations acutely terminate VT when applied in pts suffering from MVT sec. to ischemic heart disease scarring.


EASYER (EpiAccess SYstEm Registry) A post Market Observational Registry

Registry is to provide post market clinical outcome and potential health economics data and confirm the continued safety of using the USA FDA cleared and CE marked Api Access System; by evaluation the ability to access the pericardium and assess intra-procedural major complications or adverse events related to pericardial access in patients where such Epicardial access is required.


Genetics, Mechanisms and Clinical Phenotypes of Arrhythmogenic Cardiomyopathy

Subjects already diagnosed with ARVC or suspected of having ARVC.

Enrolling Studies: Devices

Adapt Response Study

A prospective, randomized, controlled, interventional, single-blinded, multi-center, post-market, global Cardiac Resynchronization Therapy (CRT) in heart failure (HF) clinical study.

Share This Page: